Search

Auditory Brainstem Response (ABR) is an evoked potential in the brainstem's neural centers in response to sound stimuli. Clinically, characteristic waves, especially Wave V latency, extracted from ABR can objectively indicate auditory loss and diagnose diseases. Several methods have been developed for the extraction of characteristic waves. To ensure the effectiveness of the method, most of the methods are time-consuming and rely on the heavy workloads of clinicians. To reduce the workload of clinicians, automated extraction methods have been developed. However, the above methods also have limitations. This study introduces a novel deep learning network for automatic extraction of Wave V latency, named ABR-Attention. ABR-Attention model includes a self-attention module, first and second-derivative attention module, and regressor module. Experiments are conducted on the accuracy with 10-fold cross-validation, the effects on different sound pressure levels (SPLs), the effects of different error scales and the effects of ablation. ABR-Attention shows efficacy in extracting Wave V latency of ABR, with an overall accuracy of 96.76±0.41% and an error scale of 0.1ms, and provides a new solution for objective localization of ABR characteristic waves.

Objective: To evaluate the efficacy and safety of balloon eustachian tuboplasty (BET) combined with ventilation tube (VT) insertion in pediatric population and to identify the predictive factors for symptom recurrence. Methods: We conducted a retrospective study between August 2018 and February 2022 at Shenzhen Children's Hospital. The study analyzed the data of pediatric patients who underwent BET + VT insertion, as well as the data of pediatric patients who underwent VT insertion alone. The outcomes were efficacy, safety, and predictive factors of BET combined with VT. Kaplan‒Meier curves were used to examine the failure-free survival rate. A multivariate Cox regression model was used to identify the independent predictors of BET failure. Results: We evaluated the data of 29 pediatric patients (48 ears) who underwent BET with VT insertion (BET + VT group) and the data of 29 pediatric patients (46 ears) who underwent VT insertion alone (VT group). The total effectiveness rates at the first follow-up after VT removal and at 12 months in the BET + VT group were 90.9% and 84.6%, respectively. The decrease in the air-bone gap (ABG) was more significant in the BET + VT group at 12 months (13.7 ± 10.8 vs 6.4 ± 15.3, P < .05). The subgroup analyses did not show any significant difference between the groups in high-risk. For non-high-risk patients, the decrease in the ABG was more significant in the BET + VT group (14.2 ± 10.6 vs 4.3 ± 13.1, P < .05) at 12 months. The multivariate analysis showed that a history of VT insertion was independently associated with a higher rate of recurrence in the BET + VT group (hazard ratio 3.177; 95% CI, 1.027-9.826; P < .05). Conclusions: BET + VT insertion is an effective procedure to decrease the ABG in pediatric patients with eustachian tube dysfunction (ETD) who have no risk factors for conventional therapy failure. Treatment of patients with ETDs who have coexisting risk factors remains a challenge that warrants further high-quality prospective research., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.